GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (FRA:OFK) » Definitions » Loans Receivable

Orion Oyj (FRA:OFK) Loans Receivable : €0 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Orion Oyj Loans Receivable?

Orion Oyj's Loans Receivable for the quarter that ended in Mar. 2024 was €0 Mil.


Orion Oyj Loans Receivable Historical Data

The historical data trend for Orion Oyj's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Loans Receivable Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orion Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orion Oyj Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Orion Oyj Loans Receivable Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj (FRA:OFK) Business Description

Address
Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj (FRA:OFK) Headlines

No Headlines